Steven Cohen's ABBV Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 366,836 shares of AbbVie Inc. (ABBV) worth $92.31 M, representing 0.10% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ABBV, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2020, adding 1.39 M shares. Largest reduction occurred in Q3 2015, reducing 1.25 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +366,836 | New Buy | 366,836 | $251.64 |
| Q4 2025 | -359,444 | Sold Out | 0 | $0.00 |
| Q3 2025 | +354,234 | Add 6799.12% | 359,444 | $231.54 |
| Q2 2025 | +5,210 | New Buy | 5,210 | $185.62 |
| Q2 2024 | -42,138 | Sold Out | 0 | $0.00 |
| Q1 2024 | -745,362 | Reduce 94.65% | 42,138 | $182.10 |
| Q4 2023 | -234,374 | Reduce 22.94% | 787,500 | $154.97 |
| Q3 2023 | +400,875 | Add 64.55% | 1.02 M | $149.06 |
| Q2 2023 | -407,901 | Reduce 39.64% | 620,999 | $134.73 |
| Q1 2023 | +1.03 M | New Buy | 1.03 M | $159.37 |
| Q1 2021 | -54,446 | Sold Out | 0 | $0.00 |
| Q4 2020 | -32,955 | Reduce 37.71% | 54,446 | $107.15 |
| Q3 2020 | -160,627 | Reduce 64.76% | 87,401 | $87.58 |
| Q2 2020 | -1.14 M | Reduce 82.17% | 248,028 | $98.18 |
| Q1 2020 | +1.39 M | New Buy | 1.39 M | $76.19 |
| Q3 2019 | -884,906 | Sold Out | 0 | $0.00 |
| Q2 2019 | +814,776 | Add 1161.81% | 884,906 | $72.72 |
| Q1 2019 | +70,130 | New Buy | 70,130 | $80.59 |
| Q3 2017 | -170,000 | Sold Out | 0 | $0.00 |
| Q2 2017 | -770,300 | Reduce 81.92% | 170,000 | $72.51 |
| Q1 2017 | -196,266 | Reduce 17.27% | 940,300 | $65.16 |
| Q4 2016 | +1.14 M | New Buy | 1.14 M | $62.62 |
| Q3 2015 | -1.25 M | Sold Out | 0 | $0.00 |
| Q2 2015 | +1.1 M | Add 760.15% | 1.25 M | $67.19 |
| Q1 2015 | +144,800 | New Buy | 144,800 | $58.54 |
| Q4 2014 | -184,300 | Sold Out | 0 | $0.00 |
| Q3 2014 | +184,300 | New Buy | 184,300 | $57.76 |
Steven Cohen's AbbVie Investment FAQs
Steven Cohen first purchased AbbVie Inc. (ABBV) in Q3 2014, acquiring 184,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held AbbVie Inc. (ABBV) for 27 quarters since Q3 2014.
Steven Cohen's largest addition to AbbVie Inc. (ABBV) was in Q1 2020, adding 1,390,906 shares worth $105.97 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 366,836 shares of AbbVie Inc. (ABBV), valued at approximately $92.31 M.
As of the Q2 2026 filing, AbbVie Inc. (ABBV) represents approximately 0.10% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in AbbVie Inc. (ABBV) was 1,390,906 shares, as reported at the end of Q1 2020.